| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.22 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |